These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12654371)

  • 41. An objective evaluation of eyedrop instillation in patients with glaucoma.
    Stone JL; Robin AL; Novack GD; Covert DW; Cagle GD
    Arch Ophthalmol; 2009 Jun; 127(6):732-6. PubMed ID: 19506189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of opticare eye drop delivery system in patients with rheumatoid arthritis.
    Averns H; Hall J; Webley M
    J Rheumatol; 1999 Dec; 26(12):2615-8. PubMed ID: 10606371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Practical problems with eye-drops among elderly ophthalmology outpatients.
    Burns E; Mulley GP
    Age Ageing; 1992 May; 21(3):168-70. PubMed ID: 1615776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study of the association between patterns of eye drop prescription and medication usage in glaucoma subjects.
    Kawai-Tsuboi N; Kawai M; Minami Y; Yoshida A
    J Glaucoma; 2015 Mar; 24(3):202-6. PubMed ID: 23807351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrasubject tear osmolarity changes with two different types of eyedrops.
    Montani G
    Optom Vis Sci; 2013 Apr; 90(4):372-7. PubMed ID: 23507972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants of eye drop size.
    Van Santvliet L; Ludwig A
    Surv Ophthalmol; 2004; 49(2):197-213. PubMed ID: 14998692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors affecting eye drop instillation in glaucoma patients with visual field defect.
    Naito T; Namiguchi K; Yoshikawa K; Miyamoto K; Mizoue S; Kawashima Y; Shiraishi A; Shiraga F
    PLoS One; 2017; 12(10):e0185874. PubMed ID: 29023521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized controlled trial of an online educational video intervention to improve glaucoma eye drop technique.
    Davis SA; Carpenter DM; Blalock SJ; Budenz DL; Lee C; Muir KW; Robin AL; Sleath B
    Patient Educ Couns; 2019 May; 102(5):937-943. PubMed ID: 30583913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
    Benelli U; Nardi M; Posarelli C; Albert TG
    Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Mydrin eye-drops on central corneal thickness values in adult patients with myopia.
    Zeng Y; Gao JH
    Clin Exp Optom; 2017 Mar; 100(2):151-154. PubMed ID: 27686663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multicenter study of compliance and drop administration in glaucoma.
    Kholdebarin R; Campbell RJ; Jin YP; Buys YM
    Can J Ophthalmol; 2008 Aug; 43(4):454-61. PubMed ID: 18711461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-term Analysis of the Residual Volume of an Eye Drop Following 23-Gauge Microincision Vitrectomy Surgery.
    Kang YK; Im JC; Shin JP; Kim IT; Park DH
    Korean J Ophthalmol; 2017 Oct; 31(5):439-445. PubMed ID: 28682023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of an eye drop booklet on distress in children when receiving eye drops.
    Pilon F; Veen H; Kef S; van Genderen MM
    Strabismus; 2020 Jun; 28(2):67-72. PubMed ID: 32351156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edema.
    Tanito M; Hara K; Takai Y; Matsuoka Y; Nishimura N; Jansook P; Loftsson T; Stefánsson E; Ohira A
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):7944-8. PubMed ID: 21896859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical treatment of dry eye using 0.03% tacrolimus eye drops.
    Moscovici BK; Holzchuh R; Chiacchio BB; Santo RM; Shimazaki J; Hida RY
    Cornea; 2012 Aug; 31(8):945-9. PubMed ID: 22511024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Usability of prostaglandin monotherapy eye droppers.
    Drew T; Wolffsohn JS
    Br J Ophthalmol; 2015 Sep; 99(9):1251-4. PubMed ID: 25761745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early results on the use of chitosan-N-acetylcysteine (Lacrimera
    Messina M; Dua HS
    Int Ophthalmol; 2019 Mar; 39(3):693-696. PubMed ID: 29549486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sjögren syndrome.
    Hwang J; Chung SH; Jeon S; Kwok SK; Park SH; Kim MS
    Cornea; 2014 Jul; 33(7):663-7. PubMed ID: 24886995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of lubricating eyedrops on ocular light scattering as a measure of vision quality in patients with dry eye.
    Diaz-Valle D; Arriola-Villalobos P; García-Vidal SE; Sánchez-Pulgarín M; Borrego Sanz L; Gegúndez-Fernández JA; Benitez-Del-Castillo JM
    J Cataract Refract Surg; 2012 Jul; 38(7):1192-7. PubMed ID: 22727288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of polyethylene covers versus carbomer drops (Viscotears) to prevent dry eye syndrome in the critically ill.
    Kocaçal Güler E; Eşer I; Eğrilmez S
    J Clin Nurs; 2011 Jul; 20(13-14):1916-22. PubMed ID: 21414053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.